Fuller & Thaler Asset Management, Inc. Abb Vie Inc. Transaction History

Fuller & Thaler Asset Management, Inc.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2018 Nov 13, 2018	SELL	$88.91 - $98.84 $942,446 - $1.05 Million	-10,600 Closed	0 $0
Q1 2018 May 14, 2018	SELL	$92.01 - $123.21 $349,638 - $468,198	-3,800 Reduced 26.39%	10,600 $1 Million
Q3 2017 Nov 08, 2017	SELL	$69.85 - $89.22 $69,850 - $89,220	-1,000 Reduced 6.49%	14,400 $1.28 Million
Q2 2017 Aug 14, 2017	BUY	N/A	15,400	15,400 $1.12 Million

3,853

1.25B

16.8M

12.2M

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $318B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

Get notified when there are updates to the investment portfolio of Fuller & Thaler Asset Management, Inc., based on Form 13F filings with the SEC.

Stay updated on Fuller & Thaler Asset Management, Inc. with notifications on news.